Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy

2021 ◽  
pp. 135975
Author(s):  
Kenta Takahashi ◽  
Kazuhiro Iwaoka ◽  
Kai Takahashi ◽  
Yoshio Suzuki ◽  
Keita Taguchi ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Parkinson’S Disease ◽  
Cerebrospinal Fluid ◽  
Progressive Supranuclear Palsy ◽  
Reactive Oxygen ◽  
Antioxidant Potential ◽  
Reactive Oxygen Metabolites ◽  
Cerebrospinal Fluid Levels ◽  
Fluid Levels ◽  
Oxygen Metabolites

scholarly journals Assessment of oxidative stress in autism spectrum disorder using reactive oxygen metabolites and biological antioxidant potential

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0233550
Author(s):  
Masahito Morimoto ◽  
Toshiaki Hashimoto ◽  
Yoshimi Tsuda ◽  
Tadanori Nakatsu ◽  
Taisuke Kitaoka ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Autism Spectrum Disorder ◽  
Reactive Oxygen ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Antioxidant Potential ◽  
Reactive Oxygen Metabolites ◽  
Oxygen Metabolites

Reference intervals for serum reactive oxygen metabolites, biological antioxidant potential, and oxidative stress index in adult rams

2017 ◽  
Vol 78 (3) ◽  
pp. 274-278 ◽  
Author(s):  
Ioannis L. Oikonomidis ◽  
Evangelos A. Kiosis ◽  
Christos N. Brozos ◽  
Maria G. Kritsepi-Konstantinou
Keyword(s):  
Oxidative Stress ◽  
Reactive Oxygen ◽  
Reference Intervals ◽  
Antioxidant Potential ◽  
Stress Index ◽  
Reactive Oxygen Metabolites ◽  
Oxidative Stress Index ◽  
And Oxidative Stress ◽  
Oxygen Metabolites

Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy

1985 ◽  
Vol 328 (2) ◽  
pp. 215-221 ◽  
Author(s):  
George S. Zubenko ◽  
Ladislau Volicer ◽  
Lorne K. Direnfeld ◽  
Morris Freeman ◽  
Philip J. Langlais ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Parkinson’S Disease ◽  
Alzheimer's Disease ◽  
Parkinson's Disease ◽  
Cerebrospinal Fluid ◽  
Angiotensin Converting Enzyme ◽  
Progressive Supranuclear Palsy ◽  
Converting Enzyme ◽  
Cerebrospinal Fluid Levels ◽  
Fluid Levels

scholarly journals Effects of Non-Surgical Periodontal Treatment on Reactive Oxygen Metabolites and Glycemic Control in Diabetic Patients with Chronic Periodontitis

Antioxidants ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1056
Author(s):  
Simone Marconcini ◽  
Enrica Giammarinaro ◽  
Saverio Cosola ◽  
Giacomo Oldoini ◽  
Annamaria Genovesi ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Glycemic Control ◽  
Systemic Inflammation ◽  
Glycated Hemoglobin ◽  
Reactive Oxygen ◽  
Periodontal Treatment ◽  
Diabetic Patients ◽  
Reactive Oxygen Metabolites ◽  
Periodontal Infection ◽  
Oxygen Metabolites

Background: Periodontal infection may contribute to poor glycemic control and systemic inflammation in diabetic patients. The aim of the present study is to evaluate the efficacy of non-surgical periodontal treatment in diabetic patients by measuring oxidative stress outcomes. Methods: Sixty diabetic patients with periodontitis were enrolled, treated with scaling and full-mouth disinfection, and randomly prescribed chlorhexidine mouthwash, antioxidant mouthwash, or ozone therapy. Reactive oxygen metabolites (ROMs), periodontal parameters, and glycated hemoglobin were measured at baseline and then at 1, 3, and 6 months after. Results: At baseline, all patients presented with pathologic levels of plasmatic ROM (388 ± 21.36 U CARR), higher than the normal population. Probing depth, plaque index, and bleeding on probing values showed significant clinical improvements after treatment, accompanied by significant reductions of plasma ROM levels (p < 0.05). At the 6-month evaluation, the mean ROM relapsed to 332 ± 31.76 U CARR. Glycated hemoglobin decreased significantly (∆ = −0.52 units) after treatment. Both the test groups showed longer-lasting improvements of periodontal parameters. Conclusion: In diabetic patients, periodontal treatment was effective at reducing plasma ROM, which is an indicator of systemic oxidative stress and inflammation. The treatment of periodontal infection might facilitate glycemic control and decrease systemic inflammation.

scholarly journals Cerebrospinal fluid levels of SNAP‐25 and SYT1 in Alzheimer’s and Parkinson’s disease

2020 ◽  
Vol 16 (S4) ◽  
Author(s):  
Ann Brinkmalm ◽  
Victoria Larsson ◽  
Shorena Janelidze ◽  
Henrik Zetterberg ◽  
Kaj Blennow ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cerebrospinal Fluid ◽  
Cerebrospinal Fluid Levels ◽  
Fluid Levels

scholarly journals Diacron reactive oxygen metabolites and biological antioxidant potential tests for patients with age-related macular degeneration

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Toshiyuki Matsuura ◽  
Hiroki Kaneko ◽  
Kei Takayama ◽  
Rei Shibata ◽  
Keiko Kataoka ◽  
...  
Keyword(s):  
Macular Degeneration ◽  
Reactive Oxygen ◽  
Age Related Macular Degeneration ◽  
Antioxidant Potential ◽  
Reactive Oxygen Metabolites ◽  
Age Related ◽  
Oxygen Metabolites

Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system

The Analyst ◽  
2019 ◽  
Vol 144 (2) ◽  
pp. 611-621 ◽  
Author(s):  
Münteha Nur Sonuç Karaboğa ◽  
Mustafa Kemal Sezgintürk
Keyword(s):  
Parkinson’S Disease ◽  
Cerebrospinal Fluid ◽  
Glutamic Acid ◽  
Gold Nanoparticle ◽  
Alpha Synuclein ◽  
Polyglutamic Acid ◽  
Cerebrospinal Fluid Levels ◽  
System P ◽  
Biosensor System ◽  
Fluid Levels

A gold nanoparticle and polyglutamic acid-modified ITO-based biosensor system to detect alpha-synuclein, an important biomarker of Parkinson's disease.

scholarly journals Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia

2017 ◽  
Vol 141 (4) ◽  
pp. 614-625 ◽  
Author(s):  
Andreas Dammann Andersen ◽  
Morten Blaabjerg ◽  
Michael Binzer ◽  
Akram Kamal ◽  
Helle Thagesen ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cerebrospinal Fluid ◽  
Cerebrospinal Fluid Levels ◽  
Disease Effect ◽  
Fluid Levels
Sign in / Sign up

Export Citation Format

Share Document